DGDébora Gomes-Medeiros

Débora Gomes-Medeiros

*This is an algorithmically generated author record based on publicly available information.

Débora Gomes-Medeiros has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Therapeutic Uses of Cannabis: An Experience with an Elective Course to Introduce the Content in Undergraduate Medical Education

    by Marcelo Colombini Ranieri, Julia Pellizon Mazucco, Heloísa Scattone, Pedro Nicoletti, Renato Filev, Débora Gomes-Medeiros

    Introduction: Cannabis sativa L. has a thousand-year history of therapeutic use and scientific evidence of clinical applicability in conditions such as chronic pain, nausea and vomiting associated with chemotherapy, epilepsy and multiple sclerosis, in addition to growing evidence of a potential positive effect in several other morbidities. This great therapeutic potential, justified by the existence of a widely distributed endocannabinoid system with pro-homeostatic functions, is still little present in undergraduate medical school curricula.

  • Open Access

    Usos terapêuticos da Cannabis: experiência de disciplina eletiva para introdução do conteúdo na graduação médica

    by Marcelo Colombini Ranieri, Julia Pellizon Mazucco, Heloísa Scattone, Pedro Nicoletti, Renato Filev, Débora Gomes-Medeiros

    Introdução: A Cannabis sativa L. possui histórico milenar de uso terapêutico e evidências científicas de aplicabilidade clínica em condições como dor crônica, náuseas e vômitos associados à quimioterapia, epilepsia e esclerose múltipla, além de crescentes evidências de potencial efeito positivo em diversas outras morbidades. Esse grande potencial terapêutico, justificado pela existência de um sistema endocanabinoide amplamente distribuído e com funções pró-homeostáticas, ainda é pouco presente nos currículos da graduação médica.

  • Rhamnetin: a review of its pharmacology and toxicity

    by Débora Lima Medeiros, Edson Thiago Gomes Lima, Jefferson Campos Silva, Mônica Alves Medeiros, Elayne Bessa Ferreira Pinheiro

    Objectives: Numerous natural products, including rhamnetin, have been studied in recent years owing to the need for new herbal remedies to treat different illnesses. This study aimed to review the salient properties of rhamnetin and its pharmacological potential and possible toxicological effects. Key findings: A search carried out in the ScienceDirect database using the term ‘rhamnetin’ yielded 573 articles published between 1977 and 2021. However, only those studies that mentioned pharmacological activity of rhamnetin were included in this study. As a result of this selection process, this study included reports that describe rhamnetin as a secondary metabolite with several pharmacological properties. Summary: Rhamnetin (2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxychromen-4-one) is a secondary metabolite, belonging to the flavonoid class, present in various plants and fruits; it has different pharmacological properties, including antioxidant, anticancer, anti-inflammatory, antiviral and antibacterial activity. However, conclusive results on the toxicology of rhamnetin have not been reported yet. Therefore, further research is needed to gather detailed information about the effects of rhamnetin.